Skip to content

Clinical study on probiotics to prevent and relieve PFAPA (Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome )

Clinical study on probiotics to prevent and relieve PFAPA (Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome )

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093377
Enrollment
Unknown
Registered
2024-12-03
Start date
2024-12-03
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PFAPA syndrome (Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome)

Interventions

Probiotic group:Daily oral intake of probiotics (containing 1×10^8 live Lactobacillus reuteri DSM17938 and 1×10^9 live Bifidobacterium longum BB536)
placebo group:Daily oral administration of placebo sunflower seed oil.

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. PFAPA patients: Age =12 years and =2 years;.fever episodes =3 times, lasting up to 5 days, with a regular interval, and fever resolves within a few hours after administration of corticosteroids; pharyngitis with adenitis or stomatitis; good health between episodes and normal growth; acute phase reactants (e.g., C-reactive protein, ESR) are elevated during fever episodes but not during inter-episode periods. Neutropenia or other atypical symptoms (e.g., cough, nasal discharge, severe abdominal pain, diarrhea, severe vomiting, rash, arthritis, or neurological dysfunction) should be excluded. 2. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Other periodic fever diseases, patients with rheumatoid arthritis complicated by infection, tumor, or other autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Severity of onset;Frequency of onset;

Countries

China

Contacts

Public ContactWenjie Zheng

The Second Affiliated Hospital of Wenzhou Medical University

wzwjzheng@sina.com+86 577 8668 9978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026